Goldman Sachs
PHAS

Goldman Sachs’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

Goldman Sachs’s Portfolio PHAS Stock Details PHAS Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
2021
Q3 		$95K Sell
2021
Q2 		$191K Buy
2021
Q1 		$45K Buy
2020
Q4 		$35K Sell
2020
Q3 		$49K Sell
2020
Q2 		$131K Sell
2020
Q1 		$160K Sell
2019
Q4 		$711K Buy
2019
Q3 		$458K Buy